Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Geoffrey Chupp

Showing results (11-20 of 58) with videos related to

Pageof 6
Sort By:
The Journal of Allergy and Clinical Immunology. in Practice|February 6, 2024
Targeting Asthma Remission as the Next Therapeutic Step Toward Improving Disease ControlWilliam W Busse, Geoffrey Chupp, Thomas Corbridge, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|May 13, 2024
Asthma control in the United States: Relationships between short-acting β<sub>2</sub>-agonist and systemic corticosteroid useGeoffrey Chupp, Kevin R Murphy, Hitesh N Gandhi, et al.
Proceedings of the American Thoracic Society|June 27, 2006
Transgenic modeling of transforming growth factor-beta(1): role of apoptosis in fibrosis and alveolar remodelingChun Geun Lee, Hye-Ryun Kang, Robert J Homer, et al.
Journal of Visualized Experiments : Jove|September 10, 2019
Measurement of Chitinase Activity in Biological SamplesAlyssa K Amick, Qing Liu, Samir Gautam, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|June 11, 2005
Yoga intervention for adults with mild-to-moderate asthma: a pilot studyAlyse B Sabina, Anna-leila Williams, Hilary K Wall, et al.
The European Respiratory Journal|March 25, 2014
The role of mepolizumab in atopic and nonatopic severe asthma with persistent eosinophiliaHector Ortega, Geoffrey Chupp, Philip Bardin, et al.
The Journal of Allergy and Clinical Immunology. in Practice|September 6, 2021
Integrated Safety and Efficacy Among Patients Receiving Benralizumab for Up to 5 YearsStephanie Korn, Arnaud Bourdin, Geoffrey Chupp, et al.
AMIA ... Annual Symposium Proceedings. AMIA Symposium|June 2, 2018
Building an Informed Consent Tool Starting with the Patient: The Patient-Centered Virtual Multimedia Interactive Informed Consent (VIC)Fuad Abujarad, Sandra Alfano, Tiffani J Bright, et al.
The Journal of Allergy and Clinical Immunology. in Practice|April 27, 2024
MELTEMI and COLUMBA: 5-Year Comparative Safety Analysis of Benralizumab and MepolizumabArnaud Bourdin, Geoffrey Chupp, David J Jackson, et al.
JMIR Formative Research|October 19, 2021
Comparing a Multimedia Digital Informed Consent Tool With Traditional Paper-Based Methods: Randomized Controlled TrialFuad Abujarad, Peter Peduzzi, Sophia Mun, et al.
Pageof 6

Showing results (11-20 of 58) with videos related to

Sort By:
Pageof 6
The Journal of Allergy and Clinical Immunology. in Practice|February 6, 2024
Targeting Asthma Remission as the Next Therapeutic Step Toward Improving Disease ControlWilliam W Busse, Geoffrey Chupp, Thomas Corbridge, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|May 13, 2024
Asthma control in the United States: Relationships between short-acting β<sub>2</sub>-agonist and systemic corticosteroid useGeoffrey Chupp, Kevin R Murphy, Hitesh N Gandhi, et al.
Proceedings of the American Thoracic Society|June 27, 2006
Transgenic modeling of transforming growth factor-beta(1): role of apoptosis in fibrosis and alveolar remodelingChun Geun Lee, Hye-Ryun Kang, Robert J Homer, et al.
Journal of Visualized Experiments : Jove|September 10, 2019
Measurement of Chitinase Activity in Biological SamplesAlyssa K Amick, Qing Liu, Samir Gautam, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|June 11, 2005
Yoga intervention for adults with mild-to-moderate asthma: a pilot studyAlyse B Sabina, Anna-leila Williams, Hilary K Wall, et al.
The European Respiratory Journal|March 25, 2014
The role of mepolizumab in atopic and nonatopic severe asthma with persistent eosinophiliaHector Ortega, Geoffrey Chupp, Philip Bardin, et al.
The Journal of Allergy and Clinical Immunology. in Practice|September 6, 2021
Integrated Safety and Efficacy Among Patients Receiving Benralizumab for Up to 5 YearsStephanie Korn, Arnaud Bourdin, Geoffrey Chupp, et al.
AMIA ... Annual Symposium Proceedings. AMIA Symposium|June 2, 2018
Building an Informed Consent Tool Starting with the Patient: The Patient-Centered Virtual Multimedia Interactive Informed Consent (VIC)Fuad Abujarad, Sandra Alfano, Tiffani J Bright, et al.
The Journal of Allergy and Clinical Immunology. in Practice|April 27, 2024
MELTEMI and COLUMBA: 5-Year Comparative Safety Analysis of Benralizumab and MepolizumabArnaud Bourdin, Geoffrey Chupp, David J Jackson, et al.
JMIR Formative Research|October 19, 2021
Comparing a Multimedia Digital Informed Consent Tool With Traditional Paper-Based Methods: Randomized Controlled TrialFuad Abujarad, Peter Peduzzi, Sophia Mun, et al.
Pageof 6